US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Antibody Technologies Market Research Reports & Industry Analysis

RSS Feeds

Antibody Technologies Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics) - Global Forecast to 2021
9/15/2016 | published by: MarketsandMarkets
... global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, ...  |  read more...
USD 5,650
Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Forecast to 2021
9/21/2016 | published by: MarketsandMarkets
... (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based on products, diseases, techniques, ...  |  read more...
USD 5,650
Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021
8/18/2016 | published by: MarketsandMarkets
... USD 13.28 billion by 2021 from USD 7.45 billion in 2016, at a CAGR of 12.3% during the forecast period of 2016 to 2021. The antibody production market comprises products required during the different stages ...  |  read more...
USD 5,650
Antibodies in Oncology: Analytical Tool
8/22/2016 | published by: BioSeeker Group AB
... business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis ...  |  read more...
USD 14,250
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
9/1/2016 | published by: Current Partnering
... companies. Trends in cancer monoclonal antibody partnering deals Most active companies in cancer monoclonal antibody partnering Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer monoclonal antibody partnering contract documents Top cancer monoclonal ...  |  read more...
USD 2,995
Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
9/1/2016 | published by: Current Partnering
... majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization ...  |  read more...
USD 2,995
Global Breast Cancer Monoclonal Antibodies Market 2016-2020
9/6/2016 | published by: TechNavio - Infiniti Research Ltd.
... of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protein stimulates the growth and division of malignant cells. ...  |  read more...
USD 2,500
Anti-CD22 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
Anti-CD28 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD33 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD38 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD4 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD52 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD80 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CS1 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Antibodies in Oncology: Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... The rational for this plethora of treatment strategies is based on our increasing understanding of the 345 drug targets that are included in this drug-pathway analyzing tool. No less than 322 of these have been ...  |  read more...
USD 6,750
Protein A Resins Market: Global Industry Analysis and Opportunity Assessment, 2016-2026
7/27/2016 | published by: Future Market Insights
... offer market dynamics such as trends, drivers, restraints and opportunities for manufacturers operating in the global protein a resin market. The report also offers value forecast for the global protein A resin market for the ...  |  read more...
USD 5,000
Global Pancreatic Beta-Cell Protection Market Analysis 2016 - Forecast to 2022
8/1/2016 | published by: Hoovers Research
... data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation ...  |  read more...
USD 4,550
T-cell Immunotherapy: Clinical Trial Tracker
7/11/2016 | published by: Roots Analysis
... promising therapeutic strategies, developed under the banner of T-cell immunotherapies, are set to hit the market in the near future. T-cells, also named as the soldiers of the immune system, are featured with specificity and ...  |  read more...
USD 949
Anti-CD19 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD25 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD30 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10